You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 254 No. 21, December 6, 1985 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Ribavirin Treatment of Respiratory Syncytial Viral Infection in Infants With Underlying Cardiopulmonary Disease

Caroline Breese Hall, MD; John T. McBride, MD; Christine L. Gala; Stephen W. Hildreth, DPH; Kenneth C. Schnabel

JAMA. 1985;254(21):3047-3051.


Abstract

Aerosolized ribavirin was evaluated in the treatment of respiratory syncytial virus lower respiratory tract disease in 53 infants, 36 of whom had underlying diseases. Of the total infants, 26 were studied in a double-blind, placebo-controlled manner; 14 received ribavirin and 12 received placebo, a water aerosol, for an average of five days. When the infants with bronchopulmonary dysplasia and congenital heart disease treated with ribavirin were compared with those receiving placebo, the treated infants showed a significantly faster rate of improvement in their illness severity score. The degree of improvement in the total group of infants receiving ribavirin compared with those receiving placebo was similarly greater, and at the end of therapy significantly greater improvement was also demonstrated in their arterial blood gas values and in the amount of virus shed from their nasal washes. No toxic or adverse effects of the aerosol therapy were observed in any of the 53 infants studied, and resistance to ribavirin did not develop in any of the respiratory syncytial virus strains isolated, despite prolonged treatment in some of the more ill infants.

(JAMA 1985;254:3047-3051)



Author Affiliations

From the Infectious Diseases Division (Dr Hall, Ms Gala, and Mr Schnabel) and the Pulmonary Division (Dr McBride), Department of Pediatrics, University of Rochester (NY) School of Medicine. Dr Hildreth is now with Praxis Biologics, Rochester, NY.


Footnotes

Presented in part at meetings of the Society for Pediatric Research and the American Pediatric Society, Washington, DC, May 8, 1985.

Reprints not available.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Diagnosis and Management of Bronchiolitis
Subcommittee on Diagnosis and Management of Bronch
Pediatrics 2006;118:1774-1793.
ABSTRACT | FULL TEXT  

Animal Pneumoviruses: Molecular Genetics and Pathogenesis
Easton et al.
Clin. Microbiol. Rev. 2004;17:390-412.
ABSTRACT | FULL TEXT  

Simultaneous Detection, Subgrouping, and Quantitation of Respiratory Syncytial Virus A and B by Real-Time PCR
Hu et al.
J. Clin. Microbiol. 2003;41:149-154.
ABSTRACT | FULL TEXT  

Impact of Respiratory Syncytial Virus Immune Globulin in 1996-1997: A Local Controlled Comparison
Redding et al.
Arch Pediatr Adolesc Med 1999;153:503-507.
ABSTRACT | FULL TEXT  

Respiratory Syncytial Virus Infection: Immune Response, Immunopathogenesis, and Treatment
Domachowske and Rosenberg
Clin. Microbiol. Rev. 1999;12:298-309.
ABSTRACT | FULL TEXT  

Severity Of Illness Models For Respiratory Syncytial Virus-Associated Hospitalization
MOLER and OHMIT
Am. J. Respir. Crit. Care Med. 1999;159:1234-1240.
ABSTRACT | FULL TEXT  

Randomised controlled trial of budesonide for the prevention of post-bronchiolitis wheezing
Fox et al.
Arch. Dis. Child. 1999;80:343-347.
ABSTRACT | FULL TEXT  

Detection of Respiratory Syncytial Virus A and B and Parainfluenzavirus 3 Sequences in Respiratory Tracts of Infants by a Single PCR with Primers Targeted to the L-Polymerase Gene and Differential Hybridization
Eugene-Ruellan et al.
J. Clin. Microbiol. 1998;36:796-801.
ABSTRACT | FULL TEXT  

Respiratory Syncytial Virus Immune Globulin Treatment of RSV Lower Respiratory Tract Infection in Previously Healthy Children
Rodriguez et al.
Pediatrics 1997;100:937-942.
ABSTRACT | FULL TEXT  

Does Ribavirin Impact on the Hospital Course of Children With Respiratory Syncytial Virus (RSV) Infection? An Analysis Using the Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) RSV Database
Law et al.
Pediatrics 1997;99:e7-e7.
ABSTRACT | FULL TEXT  

Respiratory Syncytial Virus (RSV) Immune Globulin Intravenous Therapy for RSV Lower Respiratory Tract Infection in Infants and Young Children at High Risk for Severe RSV Infections
Rodriguez et al.
Pediatrics 1997;99:454-461.
ABSTRACT | FULL TEXT  

Ribavirin for Respiratory Syncytial Virus Lower Respiratory Tract Infection: A Systematic Overview
Randolph and Wang
Arch Pediatr Adolesc Med 1996;150:942-947.
ABSTRACT  

Seasonal Respiratory Viral Infections: Impact on Infants With Chronic Lung Disease Following Discharge From the Neonatal Intensive Care Unit
Kinney et al.
Arch Pediatr Adolesc Med 1995;149:81-85.
ABSTRACT  

Atypical Extrapulmonary Presentations Of Severe Respiratory Syncytial Virus Infection Requiring Intensive Care
Njoku and Kliegman
CLIN PEDIATR 1993;32:455-460.
ABSTRACT  

Impact of Treatment Guidelines on Use of Ribavirin
Herzog et al.
Arch Pediatr Adolesc Med 1990;144:1001-1004.
ABSTRACT  

Severe Respiratory Syncytial Virus Infection in Older Children
Groothuis et al.
Arch Pediatr Adolesc Med 1990;144:346-348.
ABSTRACT  

The Inexact Use of Fisher's Exact Test in Six Major Medical Journals
McKinney et al.
JAMA 1989;261:3430-3433.
ABSTRACT  

The Exposure of Health Care Workers to Ribavirin Aerosol
Guglielmo et al.
JAMA 1989;261:1880-1881.
ABSTRACT  

Assessing Exposures of Health-Care Personnel to Aerosols of Ribavirin--California
JAMA 1988;260:1844-1845.
 

Ribavirin: Ambivalence About an Antiviral Agent
RAY
Arch Pediatr Adolesc Med 1988;142:488-489.
ABSTRACT  

Ribavirin Administration to Infants Receiving Mechanical Ventilation
Outwater et al.
Arch Pediatr Adolesc Med 1988;142:512-515.
ABSTRACT  

Roentgenographic Features of Common Pediatric Viral Respiratory Tract Infections
Wildin et al.
Arch Pediatr Adolesc Med 1988;142:43-46.
ABSTRACT  

Fatal Pneumonia in an Adult due to Respiratory Syncytial Virus
Levenson and Kantor
Arch Intern Med 1987;147:791-792.
ABSTRACT  

Vapors, Viruses, and Views: Ribavirin and Respiratory Syncytial Virus
HALL and McBRIDE
Arch Pediatr Adolesc Med 1986;140:331-332.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1985 American Medical Association. All Rights Reserved.